Marshall Wace, LLP Icad Inc Transaction History

Marshall Wace, LLP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$3.02 - $4.56 $41,280 - $62,330	-13,669 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$3.92 - $7.48 $70,654 - $134,819	-18,024 Reduced 56.87%	13,669 $62,000
Q4 2021 Feb 14, 2022	BUY	$6.7 - $11.38 $212,343 - $360,666	31,693 New	31,693 $229,000

5.45M

3.6K

14.6K

Ticker ICAD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 25,333,900
Market Cap $42.6M
Description
iCAD, Inc. provides image analysis, workflow solutions, and radiation therapy for the treatment of cancer in the United States. It operates through two segments, Cancer Detection and Cancer Therapy. The company offers PowerLook platform, which hosts the AI algorithm solutions and manages the communications between imaging acquisition systems, an...

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

Stay updated on Marshall Wace, LLP with notifications on news.